Unlocking life's possibilities
Intarcia Therapeutics, Inc. is a rapidly emerging biotech company committed to redesigning the treatment, prevention, and experience of chronic disease. The company operates with a 'No Analog' mindset, pushing boundaries with cross-disciplinary teams of scientists and entrepreneurs. Founded in 1997, it previously focused on implantable drug delivery devices and has raised significant funding.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNov 2012
Create a free account to see which investors have funded this company.
Create Free Account
Painless, convenient transdermal patient administration of therapeutic proteins and vaccines
Biopharmaceutical company focused on virology, oncology, and inflammation therapeutics.
Biotech developing EPiC peptide compounds to cross the blood-brain barrier for treating brain dis...
Escient is a clinical-stage pharmaceutical company focused on discovering and developing first-in...
Biotech developing in vivo CAR-T cell therapies. Acquired by AbbVie for $2.1B upfront in 2024.
